Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799484 · ClinicalTrials.gov registry record · Phase 4
Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT03799484 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 14 participants.
The verdict
NCT03799484, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a difference in clinical effect, duration of effect, level of discomfort and patient satisfaction in patients receiving topical anesthesia on one side of the forehead and petrolatum ointment on the other prior to Botulinum Toxin Type A administration for the treatment of forehead rhytides.
Interventions
- DRUG Botulinum toxin type A
- DRUG 2.5% lidocaine/2.5% prilocaine
- DEVICE petrolatum ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2019-06-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03799484
The ClinicalTrials.gov registry entry for NCT03799484 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Botulinum toxin type A is the first listed.
NCT03799484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03799484 about?
NCT03799484 is a clinical study titled "Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment". The purpose of this study is to determine whether there is a difference in clinical effect, duration of effect, level of discomfort and patient satisfaction in patients receiving topical anesthesia on one side of the forehead and petrolatum ointment on the other prior to Botulinum Toxin Type A admin...
What is the current status of trial NCT03799484?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2019-01-04. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03799484?
The interventions under investigation include: Botulinum toxin type A (DRUG), 2.5% lidocaine/2.5% prilocaine (DRUG), petrolatum ointment (DEVICE).
Who is sponsoring clinical trial NCT03799484?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.